Form 4: Palatin CEO Spana Boosts Equity Holdings Through Vesting
Insider Transaction Report
Palatin Technologies' President and CEO, Carl Spana, increased his beneficial ownership through the vesting of restricted share units and performance-based stock options.
Summary
- Carl Spana, President and CEO, and a Director of Palatin Technologies, Inc. (PTN), reported an increase in his beneficial ownership.
- The increase resulted from the vesting of 885 restricted share units (RSUs) and 1,326 performance-based stock options on December 9, 2025.
- The RSUs vested in three tranches: 110 units (granted June 22, 2022), 380 units (granted June 20, 2023), and 395 units (granted June 4, 2024).
- The performance-based stock options vested in three tranches: 163 options (granted June 22, 2022, with an exercise price of $362.5), 595 options (granted June 20, 2023, with an exercise price of $109.5), and 568 options (granted June 4, 2024, with an exercise price of $91.5).
- All vesting occurred upon certification by the Compensation Committee that 100% of defined performance objectives for the 18 months ending December 31, 2025, were met.
- The shares underlying the vested RSUs have not yet been issued but will be issued on or before 60 days following December 9, 2025.
- Following these transactions, Carl Spana beneficially owns 64,698 shares of common stock directly and 123,939 derivative securities (stock options) directly.
Sentiment
Score: 7
Explanation: The filing indicates positive sentiment as it reports the vesting of performance-based equity awards, suggesting the company met its performance objectives. This also increases insider ownership, which is generally viewed favorably.
Positives
- The vesting of performance-based equity awards indicates that Palatin Technologies met defined performance objectives for the 18 months ending December 31, 2025.
- Increased beneficial ownership by the President and CEO aligns management's interests more closely with those of shareholders.
Future Outlook
The shares underlying the vested restricted share units, which represent the right to receive one share of common stock each, will be issued to Carl Spana on or before the 60th day following December 9, 2025.
Industry Context
This filing represents a routine disclosure of executive compensation in the form of equity awards, common across publicly traded companies, particularly in the biotechnology and pharmaceutical sectors, to incentivize long-term performance and align management interests with shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Plan Utilization | The transactions occurred under the company's 2011 Stock Incentive Plan, demonstrating its ongoing use for executive compensation. | 2025-12-09 | Reinforces the company's established compensation structure designed to incentivize performance and align management with shareholder interests. |
| Compensation Committee Certification | The vesting of awards was contingent upon certification by the Compensation Committee of defined performance objectives being met. | 2025-12-09 | Highlights the role of the Compensation Committee in overseeing executive performance and compensation, ensuring accountability and adherence to performance metrics. |
Stakeholder Impact
- Shareholders: Increased alignment of management's interests with shareholders due to higher insider ownership, potentially signaling confidence in future performance.
- Employees: The successful vesting of performance-based awards for the CEO may serve as a positive indicator for other employees participating in similar incentive plans.
Next Steps
- Issuance of 885 common shares to Carl Spana, representing the vested restricted share units, on or before 60 days following December 9, 2025.
Key Dates
| Date | Description |
|---|---|
| 2022-06-22 | Grant date for 110 restricted share units and 163 performance-based stock options. |
| 2023-06-20 | Grant date for 380 restricted share units and 595 performance-based stock options. |
| 2024-06-04 | Grant date for 395 restricted share units and 568 performance-based stock options. |
| 2025-12-09 | Transaction date for the vesting of restricted share units and performance-based stock options. |
| 2025-12-11 | Filing date of the Form 4. |
| 2025-12-31 | End of the 18-month performance period for the vested awards. |
| 2032-06-22 | Expiration date for 163 performance-based stock options. |
| 2033-06-20 | Expiration date for 595 performance-based stock options. |
| 2034-06-04 | Expiration date for 568 performance-based stock options. |
Keywords
Palatin Technologies, PTN, Carl Spana, Form 4, Insider Transaction, Restricted Share Units, Stock Options, Equity Compensation, Performance Vesting, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.